Investigational treatments for lung cancer, Huntington’s disease and Alzheimer's gain Innovation Passports through the Innovative Licensing and Access Pathway 

Imported from official source

Three innovative medicines with the potential to meet unmet needs in lung cancer, Huntington’s disease and Alzheimer’s disease have been given Innovation Passports, the Medicines and Healthcare products Regulatory Agency (MHRA) announced today. 

This version

Version
1 of 1
Recorded
November 09, 2026 10:02
Change
Initial
Content hash
5375e8e0c43caeceea3c1920d4a2d27c
All versions
Revision history

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.